Keaven Posted - 04/23/24

$BSEM price target 18... seems high given lack of volume, 12 appears to be a no brainer until the volume picks up.

Finanz Posted - 04/15/24

$BSEM Just receive an e-mail--There are plenty of reasons why this growing biotech company should be on your watchlist, including an $18.70 price target! The biotech space is anticipated for a big rebound this year and one company that looks well-positioned to stand out is BioStem Technologies, Inc. (OTCQB: BSEM). In the last year, the company’s share price has moved from around $1 to over $9. It’s evident that Wall Street is paying attention to this biotech company’s game-changing offerings for the global wound care market. The company is making waves for its focus on harnessing elements of perinatal tissue derived from the human placenta for manufacturing structural tissue allografts to heal wounds. The market for improved wound care products is growing exponentially. In terms of revenue, the global wound care market in terms of revenue was estimated to be worth $20.8 billion in 2022 and is poised to reach $27.2 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027.

TheSkipper Posted - 04/10/24

$BSEM Looks like it is making a Triple Top. Can it bust through or be pushed back?

jquailey Posted - 04/10/24

$BSEM $14.80 today

jquailey Posted - 04/09/24

$BSEM 🚀

CrayP Posted - 1 month ago

$BSEM I wish this company had reasonable disclosure... impossible to analyze when they don't release much behind their financials and sponsor erroneous research. Pink sheet stocks don't trade at high multiples... and here multiples of what I do not know.

jquailey Posted - 1 month ago

$BSEM should go much higher

jquailey Posted - 1 month ago

$BSEM 🚀

CrayP Posted - 1 month ago

$BSEM Zack's was looking for adjusted EPS of 47 cents on $11.4M in sales last quarter and they hit the revenue number but lost money. If you include the distributor fees and use FD shares AEPS for '24comes to around $1 and if you tax that probably around 70 cents. The Zack's analyst is not projecting much growth in 2025 but don't know what to make of that. The company is appearing at a conference next week... not sure if that is an opportunity to ride or sell.

CrayP Posted - 1 month ago

$BSEM Beware of an offering coming at a steep discount. They have very little cash, $11M tied up in A/R and a large payable due to their distributor. Due to limited history, it is unclear how long it will take for them to collect or what the terms are with respect to paying their distributor, but they seem to have very limited working capital. The Zacks report, which is paid for by the company, is worthless (at least in my opinion) and doesn't capture marketing expenses nor other capital required for growth... not to mention taxes which is how the analyst came up with $55M in sales and $46M in Adjusted Net Income... a ridiculous net income margin and if divided by the 21M fully diluted shares outstanding accounting for stock comp would come to a little over $2 per share instead of $3. I started my due dil wanting to buy but there is a reason this is pink sheets. Given their negative shareholder equity, they would have to do an offering to qualify for uplisting anyway. Good luck to all

jquailey Posted - 1 month ago

$BSEM should break $14 today

osubuck30 Posted - 1 month ago

$BSEM new research report…. I’m a buyer if it pulls back to $10. https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_04022024_BSEM_Sorensen.pdf

osubuck30 Posted - 1 month ago

$BSEM Looks like adjusted EBITDA margin way lower than what Zack’s was assuming. This is what I was using: https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_02012024_BSEM_Sorensen.pdf

osubuck30 Posted - 1 month ago

$BSEM didn’t meet Zack’s small cap estimate….

CrayP Posted - 1 month ago

$BSEM Wow! This has got a $300M market cap including all the stock comp shares... if going to use non-gaap estimates. Plus negative equity so can't uplist for a while unless they do an offering. Gonna wait it out here, but interesting longer term.

jquailey Posted - 1 month ago

$BSEM 🔥

CrayP Posted - 1 month ago

$BSEM Explosive revenue growth and high gross margins so trying to due diligence the story a bit. Pink Sheet so financials not clear cut but looks like they lost ($0.17) EPS in Q4 on the $11M+ in sales and run rate revenues not supposed to grow that much... est $55M in '24 and '$60M in '25. Where the EPS growth coming from?

CrayP Posted - 1 month ago

$BSEM Flagged for stock promotion by OTC Markets... anybody know what's going on? https://www.otcmarkets.com/stock/BSEM/overview

jquailey Posted - 1 month ago

$BSEM $16 today 🔥

osubuck30 Posted - 1 month ago

$BSEM I have a ton of capital I will add after earnings…. Going to be next $MOD.

jquailey Posted - 1 month ago

$BSEM will be $20+ by end of week

c12312 Posted - 03/28/24

$NKLA between Nkla and $BSEM today has been great and the future looks really good!

osubuck30 Posted - 03/28/24

$BSEM 15 PE on 2024 earnings is $40

osubuck30 Posted - 03/15/24

$BSEM eventually will be $20 plus

ProactiveTrader Posted - 2 months ago

$BSEM

prismmarketview Posted - 02/26/24

$BSEM https://finance.yahoo.com/news/prism-marketview-spotlights-biostem-technologies-153900964.html

Handstiedbull Posted - 02/16/24

$LUNR Going for $9. $ARM $ALAR $BSEM $LLAP

Stevewits Posted - 3 months ago

$BSEM Does anyone have technicals or feedback on todays decline in this stock. It might just be a correction.

Stocks4thought Posted - 01/31/24

$BSEM WTF is up with this stock ot $SLNO

Stock_Titan Posted - 01/11/24

$BSEM BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role